Ellevest Inc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $590K | Buy |
13,811
+1,725
| +14% | +$93.7K | 0.07% | 214 |
|
|
2026
Q1 | $758K | Buy |
12,086
+1,261
| +12% | +$101K | 0.11% | 139 |
|
|
2025
Q4 | $1.03M | Sell |
10,825
-462
| -4% | -$45.3K | 0.14% | 93 |
|
|
2025
Q3 | $1.1M | Sell |
11,287
-2,442
| -18% | -$253K | 0.16% | 96 |
|
|
2025
Q2 | $1.47M | Sell |
13,729
-979
| -7% | -$99.1K | 0.24% | 62 |
|
|
2025
Q1 | $1.48M | Buy |
14,708
+785
| +6% | +$79K | 0.1% | 71 |
|
|
2024
Q4 | $1.24M | Buy |
13,923
+650
| +5% | +$57.2K | 0.07% | 90 |
|
|
2024
Q3 | $1.11M | Buy |
13,273
+371
| +3% | +$29.2K | 0.06% | 99 |
|
|
2024
Q2 | $994K | Buy |
12,902
+888
| +7% | +$65K | 0.06% | 99 |
|
|
2024
Q1 | $823K | Buy |
12,014
+149
| +1% | +$9.58K | 0.05% | 124 |
|
|
2023
Q4 | $686K | Buy |
11,865
+145
| +1% | +$7.74K | 0.05% | 132 |
|
|
2023
Q3 | $619K | Buy |
11,720
+641
| +6% | +$33.6K | 0.05% | 124 |
|
|
2023
Q2 | $599K | Buy |
11,079
+683
| +7% | +$35.7K | 0.05% | 121 |
|
|
2023
Q1 | $520K | Buy |
10,396
+1,432
| +16% | +$67.5K | 0.04% | 128 |
|
|
2022
Q4 | $415K | Buy |
8,964
+1,467
| +20% | +$63.5K | 0.03% | 162 |
|
|
2022
Q3 | $290K | Sell |
7,497
-1,380
| -16% | -$55.4K | 0.03% | 189 |
|
|
2022
Q2 | $331K | Buy |
8,877
+2,042
| +30% | +$83.1K | 0.03% | 177 |
|
|
2022
Q1 | $303K | Buy |
6,835
+438
| +7% | +$19K | 0.03% | 234 |
|
|
2021
Q4 | $272K | Sell |
6,397
-30
| -0.5% | -$1.26K | 0.02% | 233 |
|
|
2021
Q3 | $279K | Buy |
6,427
+2,199
| +52% | +$97.3K | 0.03% | 206 |
|
|
2021
Q2 | $181K | Buy |
4,228
+1,473
| +53% | +$62K | 0.02% | 277 |
|
|
2021
Q1 | $106K | Buy |
2,755
+444
| +19% | +$16.8K | 0.01% | 331 |
|
|
2020
Q4 | $83K | Sell |
2,311
-765
| -25% | -$27.6K | 0.01% | 351 |
|
|
2020
Q3 | $118K | Buy |
3,076
+1,015
| +49% | +$39.1K | 0.02% | 214 |
|
|
2020
Q2 | $72K | Buy |
2,061
+1,043
| +102% | +$37.6K | 0.02% | 296 |
|
|
2020
Q1 | $33K | Buy |
1,018
+575
| +130% | +$22.5K | 0.01% | 316 |
|
|
2019
Q4 | $20K | Buy |
443
+268
| +153% | +$11.2K | 0.01% | 412 |
|
|
2019
Q3 | $7K | Buy |
175
+45
| +35% | +$1.91K | ﹤0.01% | 247 |
|
|
2019
Q2 | $6K | Buy |
130
+53
| +69% | +$2.04K | ﹤0.01% | 281 |
|
|
2019
Q1 | $3K | Sell |
77
-84
| -52% | -$3.21K | ﹤0.01% | 261 |
|
|
2018
Q4 | $6K | Buy |
+161
| New | +$5.84K | ﹤0.01% | 407 |
|
Other funds holding BSX
Ellevest Inc's BSX Position: Q2 2026 in Review
Ellevest Inc increased its Boston Scientific (BSX) stake by 14% in Q2 2026, buying an estimated $93.7K and bringing the position to 13,811 shares worth $590K. The position accounts for 0.07% of the portfolio, ranked #214.
Ellevest Inc first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.48M in Q1 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Ellevest Inc held 13,811 shares of Boston Scientific worth $590K as of Q2 2026.
- Ellevest Inc bought 1,725 Boston Scientific shares in Q2 2026, an estimated $93.7K.
- Boston Scientific made up 0.07% of Ellevest Inc's portfolio in Q2 2026, its #214 holding.
- Ellevest Inc first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
- Ellevest Inc's Boston Scientific position peaked at $1.48M in Q1 2025.
- 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.